Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Other Non-Current Liabilities (2022 - 2026)

Moolec Science (MLECW) posted Other Non-Current Liabilities of $300000.0 for Q1 2026, up 71.12% sequentially from $175316.0 in Q4 2025.

Moolec Science (MLECW) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends

Moolec Science has reported Other Non-Current Liabilities for 5 years, with the latest figure at $300000.0 in Q1 2026.

  • Quarterly Other Non-Current Liabilities changed N/A year-over-year to $300000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $300000.0 (changed N/A YoY) and the FY2025 annual result came in at $16.2 million, down 7.61% from the prior year.
  • Other Non-Current Liabilities advanced to $300000.0 in Q1 2026 per MLECW's latest filing, from $175316.0 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $17.5 million in Q2 2024 and troughed at $175316.0 in Q4 2025.
  • A 5-year average of $3.6 million and a median of $1.2 million in 2023 frame the typical range for Other Non-Current Liabilities.
  • The widest YoY moves for Other Non-Current Liabilities: up 937.27% in 2024, down 68.08% in 2024.
  • Over 5 years, Other Non-Current Liabilities stood at $1.7 million in 2022, then declined by 28.52% to $1.2 million in 2023, then plunged by 58.48% to $494578.0 in 2024, then sank by 64.55% to $175316.0 in 2025, then soared by 71.12% to $300000.0 in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $300000.0, $175316.0, and $16.2 million for Q1 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Moolec Science 8,617.72 -1.19 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 300,000.00
Dec 31, 2025 175,316.00
Jun 30, 2025 16.15 Mn
Dec 31, 2024 494,578.00
Sep 30, 2024 587,111.00
Jun 30, 2024 17.48 Mn
Mar 31, 2024 1.25 Mn
Dec 31, 2023 1.19 Mn
Sep 30, 2023 1.84 Mn
Jun 30, 2023 1.69 Mn
Mar 31, 2023 356,757.00
Dec 31, 2022 1.67 Mn